Back to top

Veracyte price target raised to $65 from $45 at Guggenheim

Guggenheim analyst Subbu Nambi raised the firm’s price target on Veracyte (VCYT) to $65 from $45 and keeps a Buy rating on the shares. The firm adj...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Veracyte, Inc. (VCYT)